Plus Therapeutics Inc.

NASDAQ: PSTV · Real-Time Price · USD
0.63
0.09 (16.19%)
At close: Aug 15, 2025, 3:59 PM
0.57
-9.98%
After-hours: Aug 15, 2025, 07:58 PM EDT

Plus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
76K 8.55M 18.12M 18.4M
Short-Term Investments
3.53M n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
12K 32K 12K 16K
Receivables
571K n/a n/a 7K
Inventory
n/a n/a n/a n/a
Other Current Assets
436K n/a n/a n/a
Total Current Assets
5.26M 9.83M 21.82M 19.72M
Property-Plant & Equipment
521K 1.11M 1.57M 1.82M
Goodwill & Intangibles
841K 414K 466K 423K
Total Long-Term Assets
1.37M 1.55M 2.05M 2.26M
Total Assets
6.63M 11.39M 23.87M 21.98M
Account Payables
9.47M 4.76M 8.36M 2.61M
Deferred Revenue
n/a n/a n/a 141K
Short-Term Debt
3.34M 3.98M 1.72M 1.72M
Other Current Liabilities
2.74M 370K 346K 263K
Total Current Liabilities
15.55M 10.73M 11.85M 5.87M
Long-Term Debt
n/a n/a 3.79M 5M
Other Long-Term Liabilities
n/a 1.92M 1.64M 1K
Total Long-Term Liabilities
31K 2.01M 5.57M 5.28M
Total Liabilities
15.58M 12.74M 17.42M 11.14M
Total Debt
3.37M 4.18M 5.64M 6.99M
Common Stock
6K 5K 34K 16K
Retained Earnings
-493.48M -480.5M -467.19M -446.91M
Comprehensive Income
n/a -0.00 n/a n/a
Shareholders Equity
-8.95M -1.35M 6.45M 10.84M
Total Investments
3.53M n/a n/a n/a